Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.560
-0.005 (-0.32%)
At close: Mar 4, 2026, 4:00 PM EST
1.590
+0.030 (1.92%)
After-hours: Mar 4, 2026, 5:17 PM EST
Daré Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 541.03% from the current stock price of 1.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 2, 2025.
Analyst Ratings
The average analyst rating for Daré Bioscience stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +669.23% | Dec 2, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +412.82% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +669.23% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +669.23% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +669.23% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
385.82K
from 9.78K
Increased by 3,843.33%
Revenue Next Year
33.95M
from 385.82K
Increased by 8,700.33%
EPS This Year
-1.68
from -0.48
EPS Next Year
-0.36
from -1.68
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.5M | 59.4M | ||||
| Avg | 385,815 | 34.0M | ||||
| Low | n/a | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14,924.5% | 15,297.0% | ||||
| Avg | 3,843.3% | 8,700.3% | ||||
| Low | - | 2,440.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.55 | 1.29 | ||||
| Avg | -1.68 | -0.36 | ||||
| Low | -1.82 | -1.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.